Business & Government
IBM Tries To Sell Watson Health Again
Big Blue wants out of health care, after spending billions to stake its claim, just as rival Oracle is moving big into the sector via its $28 billion bet for Cerner. IBM spent more than $4 billion to build Watson Health via a series of acquisitions. The business now includes health care data and analytics business Truven Health Analytics, population health company Phytel, and medical imaging business Merge Healthcare. IBM first explored a sale of the division in early 2021, with Morgan Stanley leading the process. WSJ reported at the time that the unit was generating roughly $1 billion in annual revenue, but was unprofitable. Sources say it continues to lose money.